University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.


  1. Home


  2. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.


  3. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.

rakerr2

Devine EB, Cross JT, Kowdley KV, Sullivan SD. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin. Curr Med Res Opin. 2007 Jun;23(6):1463-72. Epub 2007 May 17.

Upcoming Events

Full Calendar

News Categories